Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Open Access Platform Desktop Spotter To Be Unveiled At Analytica in Germany
Thursday, March 27, 2014
Poly-Pico Technologies Ltd. are showcasing their new open access platform desktop ‘Pico Spotter™’ at Analytica Munich in Germany next month.

TATAA and MultiD Launch GenEx 6
Saturday, March 15, 2014
The software most compliant with guidelines for the analysis of real-time PCR data.

Eppendorf Launches New Mastercycler nexus X2
Friday, March 14, 2014
Provides solution for simultaneous PCR runs.

QIAGEN Expands GeneGlobe Web Portal
Tuesday, March 11, 2014
Portal now includes interactive access to extensive genomic content from Ingenuity’s Knowledge Base.

Integromics Releases New Version of its qPCR Data Analysis Software
Friday, February 28, 2014
RealTime StatMiner® V5.0 software enhances functionality and improves customer experience.

New TouchTools™ PCR Wizard from Tecan
Wednesday, February 26, 2014
New tool aids automated PCR set-up and reduce training time and costs.

Rubicon Launches PicoPLEX™ DNA-seq for Illumina NGS Platforms
Tuesday, February 11, 2014
PicoPLEX™ single-cell library preparation kits for IVF and other applications now available for sequencing on Illumina platforms.

EKF Molecular to Showcase PointMan™ DNA-enrichment Kits
Monday, February 10, 2014
EKF Diagnostics’ subsidiary company is exhibiting its ground-breaking technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.

Hamilton Robotics Launches NIMBUS PCR Workstation
Monday, January 27, 2014
Compact liquid handling workstation is flexible enough to change with users PCR assays.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 586
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv